期刊
PROSTATE
卷 72, 期 16, 页码 1746-1756出版社
WILEY
DOI: 10.1002/pros.22527
关键词
prostate cancer; cancer stem cells; radiotherapy; resistance
资金
- NCI
- NIH [N01-CO-12400]
- Intramural Research Fund
- National Research Foundation of Korea (NRF) [2010-0013063]
- National Research Foundation of Korea [2010-0013063] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
BACKGROUND. Despite improvements in treatment, prostate cancer (PC) remains the second-leading cause of cancer death in men. Radiotherapy is among the first-line treatments for PC, but a significant number of patients relapse. Recent evidence supports the idea that PC is initiated by a subset of cells, termed cancer stem cells (CSCs). CSCs have also been implicated in radioresistance in various malignancies, but their role in PC has not yet been investigated. METHODS. We compared the relative radiosensitivity of isolated CSCs to the total population of their corresponding cell lines, and examined the relative numbers of CSCs in irradiated cell lines following long-term recovery and in recurrent human PC. RESULTS. Here, we show that while irradiation does not immediately favor increased survival of CSCs, irradiated PC cell lines showed an increase in CSC properties with long-term recovery. These data suggest that, although CSCs are initially damaged by radiation, they possess a greater capacity for recovery and regrowth. CONCLUSIONS. The combination of radiotherapy with a CSC-targeted therapeutic strategy may prevent tumor recurrence. Prostate 72: 1746-1756, 2012. (C) 2012 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据